Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Simavita’s Smart Incontinence Management (SIM) platform improves the management of urinary incontinence in residential care settings. Our forecasts indicate that the A$8m (net) capital raise in April 2015 may make the company fully funded to profitability, which we forecast to be achieved in FY17. Our DCF valuation is A$107m (vs A$100m) or A$1.16/share.
Simavita’s SIM (Smart Incontinence Management) platform has been well received among key early adopters, for its ability to improve management of urinary incontinence in residential care settings. Simavita has appointed its first European distributor, Abena A/S in Denmark, after a successful trial in Copenhagen. We expect sales to accelerate as aged care providers complete assessment of trial sites, but additional funding may be required near term. Our DCF model suggests a valuation of A$100m.
Simavita’s FY14 results highlight the progress being achieved, with the launch in the important US market tracking in line with our expectations. The proprietary SIM (Smart Incontinence Management) platform appears to have been well received among the key early adopters, where its ability to improve the outcomes and costs associated with urinary incontinence in residential care settings has been understood. The next 12 to 18 months should mark the defining events on Simavita’s journey toward...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.